See also this year's filing and all EDGAR filings for this company.
PDF Report 0001059784_2021_Generex_Biotechnology_CORP.pdf
Logs
| warning | The stock price does not exist | industry.us_generic | {} |
| warning | Missing logo | subcommand.report | {} |
Graph
Absolute values for 0001059784, Generex Biotechnology CORP
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 1,254,847 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 43,854,868 |
| 2 | PropertyPlantAndEquipmentNet | 213,668 |
| 3 | remainder_Assets | 59,561 |
| 4 | LiabilitiesCurrent | 41,371,454 |
| 5 | LiabilitiesNoncurrent | 0 |
| 6 | remainder_Liabilities | 11,895,862 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 17,898,239 |
| 9 | ResearchAndDevelopmentExpense | 2,106,364 |
| 10 | remainder_Expenses | 12,587,193 |
| 11 | remainder_Revenues | 0 |
| 12 | remainder_NetIncome | -1,640,297 |
| 13 | remainder_ComprehensiveNetIncome | 0 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 45,382,944 |
| 1 | Liabilities | 53,267,316 |
| 2 | Expenses | 32,591,796 |
| 3 | Revenues | 0 |
| 4 | StockholdersEquity | -7,884,372 |
| 5 | NetIncome | -34,232,093 |
| 6 | ComprehensiveNetIncome | -34,232,093 |
| 7 | BaseVar | 66,441,176 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | -1.04 |
| 9 | EconomicCapitalRatio | 1.29 |
Edgar->Model Mapping
Feature Distribution
